Digitally Programmable Over-Brain Therapeutic

# Digitally Programmable Over-Brain Therapeutic **Aliases:** DOT **Entity class:** Research program or project **Collection:** [[collections/Neurotech|Neurotech]] ## Definition **Digitally Programmable Over-Brain Therapeutic** is a research program or project. [[wiki/Motif Neurotech|Motif Neurotech]] develops **Digitally Programmable Over-Brain Therapeutic**. Miniature therapeutic brain stimulator. Digitally Programmable Over-Brain Therapeutic uses [[wiki/Magnetoelectric Power Transfer|Magnetoelectric Power Transfer]]. Material converts magnetic fields into electrical pulses. millimeter-scale transduction. distinct from distributed MENPs. The entry centers on the subject's documented function, history, applications, and place within the surrounding system. ## Relationships  This entry is routed through [[collections/Neurotech|Neurotech]]. Its source context is developed in [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]], and [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Additional Documented Relationships - [[wiki/Motif Neurotech|Motif Neurotech]] develops **Digitally Programmable Over-Brain Therapeutic**. Miniature therapeutic brain stimulator. - **Digitally Programmable Over-Brain Therapeutic** uses [[wiki/Magnetoelectric Power Transfer|Magnetoelectric Power Transfer]]. Material converts magnetic fields into electrical pulses. millimeter-scale transduction. distinct from distributed MENPs.  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Resolved aliases:** `DOT` **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 173 — `uses` → [[wiki/Magnetoelectric Power Transfer|wireless magnetoelectric power transfer]]** — **VERIFIED**; evidence `MOTIF_2024`. Material converts magnetic fields into electrical pulses; millimeter-scale transduction, distinct from distributed MENPs. - **Edge 174 — `attribute` → 9 mm width; 14.5 V stimulation demonstrated** — **VERIFIED**; evidence `MOTIF_2024`. Preserve as reported device attributes from 2024 Rice demonstration. #### Incoming typed edges - **Edge 172 — [[wiki/Motif Neurotech|Motif Neurotech]] `develops` → this entry** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_TRIAL_2026`. Miniature therapeutic brain stimulator.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0306 — Strongly indicated.** A stimulation parameter can be changed instantly and reversibly, while a pharmaceutical dose cannot be recalled once administered. Reversibility gives electrical therapeutics a control-theoretic advantage that will move indications from drugs to devices wherever a nerve carries the signal. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0308 — Analytic.** An implanted device that receives software updates has a therapeutic profile that changes after implantation, without a new procedure or necessarily a new approval. The body's regulatory behavior becomes a function of a release cycle, which is a genuinely new relationship between a person and a vendor. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0310 — Plausible.** Engineered bacteria that sense a molecular condition and secrete a response are programmable therapeutic agents that replicate and persist. A living, self-maintaining drug factory inside the gut is a biological implant with no power budget, and it is under clinical development. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0314 — Plausible.** Structural DNA nanotechnology produces devices that open in response to a molecular key, which is targeted actuation at the nanoscale using a programmable material. The construction method scales through synthesis rather than through fabrication, which is an unusual and favorable scaling law. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0316 — Plausible.** Payloads released by ultrasound, magnetic field, or light give an external operator temporal control over an internal event. Separating delivery from activation means a therapeutic can be positioned in advance and fired on a schedule the clinician chooses. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]]